Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Amarantus Bioscience Holdings (AMBS) Message Board

Here is an easy catalyst that doesn't involve AMBS

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 30067
Posted On: 12/16/2014 12:34:12 PM
Posted By: Daveludlow
Here is an easy catalyst that doesn't involve AMBS receiving partnership money but which nevertheless would move the stock above .12 cents immediately: LYMPRO'S FIRST WORK ORDER to be used in a clinical trial.

AMBS has shown Lympro to the Alzheimer's world at the Conferences in July, and surely they've been in contact with AD pharmas since then making them aware of Lympro's December launch. Therefore, one would think we'd have nabbed at least one, if not two or three pharmas by now to give us a try at saving them clinical trial money?

Forget all our other catalysts, evidence that Lympro is being accepted by the Alzheimer's world would give Lympro and AMBS and Gerald the credibility they all so desperately need! I don't really care about how much money the first few pharmas pay us, the big revenue will come in time if Lympro is embraced by the industry. It wouldn't take too many work orders for the market to become convinced that LymPro is going to be huge.

If we don't have a single work order by the end of December, then 2015 is going to be slower than most of us hoped. If LymPro is hot and big pharma wants it....we should have AT LEAST one work order by year end. That would move us well above .12 cents all by itself!

Then, the Retinitis orphan, Eltoprazine 2b trial, and ESS and everything else AMBS has going.....will loom so much larger! Whether AMBS management is aware of it or not, the market doesn't really care about anything else we have until it sees signs of revenue from Lympro. We're riding on Lympro's back right now.


(0)
(0)




Amarantus Bioscience Holdings (AMBS) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us